Lipopolysaccharide up-regulates MHC class II expression on dendritic cells through an AP-1 enhancer without affecting the levels of CIITA

Journal of Immunology

Volumn 178, Issue 10, 2007, Pages 6307-6315

  Casals, Cristina ^a   Barrachina, Marta ^a   Serra, Maria ^a   Jorge Lloberas, ^a   Celada, Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; MESSENGER RNA;

ANIMAL CELL; ARTICLE; DENDRITIC CELL; GENE EXPRESSION; IMMUNOPRECIPITATION; MUTATION; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; TRANSIENT TRANSFECTION; UPREGULATION;

EID: 34248217027     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.10.6307     Document Type: Article

References (64)

1. Watts, C. 2004. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat. Immunol. 5: 685-692.
2. LeGuern, C. 2003. Regulation of T-cell functions by MHC class II self-presentation. Trends Immunol. 24: 633-638.
3. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10: 13-49.
4. Reith, W., and B. Mach. 2001. The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 19: 331-373.
5. Grusby, M. J., and L. H. Glimcher. 1995. Immune responses in MHC class II-deficient mice. Annu. Rev. Immunol. 13: 417-435.
6. Bottazzo, G. F., R. Pujol-Borrell, T. Hanafusa, and M. Feldmann. 1983. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2: 1115-1119.
7. Foulis, A. K., and M. A. Farquharson. 1986. Aberrant expression of HLA-DR antigens by insulin-containing β-cells in recent-onset type I diabetes mellitus. Diabetes 35: 1215-1224.
8. Benoist, C., and D. Mathis. 1990. Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu. Rev. Immunol. 8: 681-715.
9. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14: 301-331.
10. Ting, J. P., and J. Trowsdale. 2002. Genetic control of MHC class II expression. Cell 109(Suppl.): S21-S33.
11. Cullell-Young, M., M. Barrachina, C. Lopez-Lopez, E. Gonalons, J. Lloberas, C. Soler, and A. Celada. 2001. From transcription to cell surface expression, the induction of MHC class II I-Aα by interferon-γ in macrophages is regulated at different levels. Immunogenetics 53: 136-144.
12. Gonalons, E., M. Barrachina, J. A. Garcia-Sanz, and A. Celada. 1998. Translational control of MHC class II I-A molecules by IFN-γ. J. Immunol. 161: 1837-1843.
13. Masternak, K., A. Muhlethaler-Mottet, J. Villard, M. Zufferey, V. Steimle, and W. Reith. 2000. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 14: 1156-1166.
14. Raetz, C. R., R. J. Ulevitch, S. D. Wright, C. H. Sibley, A. Ding, and C. F. Nathan. 1991. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 5: 2652-2660.
15. Barrachina, M., E. Gonalons, and A. Celada. 1999. LPS upregulates MHC class II I-A expression in B lymphocytes at transcriptional and at translational levels. Tissue Antigens 54: 461-470.
16. Rescigno, M., S. Citterio, C. Thery, M. Rittig, D. Medaglini, G. Pozzi, S. Amigorena, and P. Ricciardi-Castagnoli. 1998. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc. Natl. Acad. Sci. USA 95: 5229-5234.
17. Lee, K. W., Y. Lee, D. S. Kim, and H. J. Kwon. 2006. Direct role of NF-κB activation in Toll-like receptor-triggered HLA-DRA expression. Eur. J. Immunol. 36: 1254-1266.
18. Celada, A., M. J. Klemsz, and R. A. Maki. 1989. Interferon-γ activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I-A β, tumor necrosis factor and complement component C3 in mouse macrophages. Eur. J. Immunol. 19: 1103-1109.
19. Sicher, S. C., G. W. Chung, M. A. Vazquez, and C. Y. Lu. 1995. Augmentation or inhibition of IFN-γ-induced MHC class II expression by lipopolysaccharides: the roles of TNF-α and nitric oxide, and the importance of the sequence of signaling. J. Immunol. 155: 5826-5834.
20. Kim, K. J., C. Kanellopoulos-Langevin, R. M. Merwin, D. H. Sachs, and R. Asofsky. 1979. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J. Immunol. 122: 549-554.
21. Girolomoni, G., M. B. Lutz, S. Pastore, C. U. Assmann, A. Cavani, and P. Ricciardi-Castagnoli. 1995. Establishment of a cell line with features of early dendritic cell precursors from fetal mouse skin. Eur. J. Immunol. 25: 2163-2169.
22. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
23. Yao, Y., Q. Xu, M. J. Kwon, R. Matta, Y. Liu, S. C. Hong, and C. H. Chang. 2006. ERK and p38 MAPK signaling pathways negatively regulate CITTA gene expression in dendritic cells and macrophages. J. Immunol. 177: 70-76.
24. Fenton, M. J., and D. T. Golenbock. 1998. LPS-binding proteins and receptors. J. Leukocyte Biol. 64: 25-32.
25. Huber, M., C. Kalis, S. Keck, Z. Jiang, P. Georgel, X. Du, L. Shamel, S. Sovath, S. Mudd, B. Beutler, et al. 2006. R-form LPS, the master key to the activation of TLR4/MD-2-positive cells. Eur. J. Immunol. 36: 701-711.
26. Celada, A., F. E. Borras, C. Soler, J. Lloberas, M. Klemsz, C. van Beveren, S. McKercher, and R. A. Maki. 1996. The transcription factor PU.1 is involved in macrophage proliferation. J. Exp. Med. 184: 61-69.
27. Herrero, C., L. Marques, J. Lloberas, and A. Celada. 2001. IFN-γ-dependent transcription of MHC class II IA is impaired in macrophages from aged mice. J. Clin. Invest. 107: 485-493.
28. Marques, L., M. Brucet, J. Lloberas, and A. Celada. 2004. STAT1 regulates lipopolysaccharide- and TNF-α-dependent expression of transporter associated with antigen processing 1 and low molecular mass polypeptide 2 genes in macrophages by distinct mechanisms. J. Immunol. 173: 1103-1110.
29. Celada, A., M. Shiga, M. Imagawa, J. Kop, and R. A. Maki. 1988. Identification of a nuclear factor that binds to a conserved sequence of the I-A β gene. J. Immunol. 140: 3995-4002.
30. Brucet, M., L. Marques, C. Sebastian, J. Lloberas, and A. Celada. 2004. Regulation of murine TapI and Lmp2 genes in macrophages by interferon γ is mediated by STAT1 and IRF-1. Genes Immun. 5: 26-35.
31. Sawka-Verhelle, D., L. Escoubet-Lozach, A. L. Fong, K. D. Hester, S. Herzig, P. Lebrun, and C. K. Glass. 2004. PE-1/METS, an antiproliferative Ets repressor factor, is induced by CREB-1/CREM-1 during macrophage differentiation. J. Biol. Chem. 279: 17772-17784.
32. Caelles, C., J. M. Gonzalez-Sancho, and A. Munoz. 1997. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev. 11: 3351-3364.
33. waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis. Immunity 11: 103-113.
34. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
35. Reith, W., S. LeibundGut-Landmann, and J. M. Waldburger. 2005. Regulation of MHC class II gene expression by the class II transactivator. Nat. Rev. Immunol. 5: 793-806.
36. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75: 135-146.
37. te Poele, R. H., A. L. Okorokov, and S. P. Joel. 1999. RNA synthesis block by 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) triggers p53-dependent apoptosis in human colon carcinoma cells. Oncogene 18: 5765-5772.
38. Brewer, G. 1991. An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol. Cell. Biol. 11: 2460-2466.
39. Heinemeyer, T., X. Chen, H. Karas, A. E. Kel, O. V. Kel, I. Liebich, T. Meinhardt, I. Reuter, F. Schacherer, and E. Wingender. 1999. Expanding the TRANSFAC database towards an expert system of regulatory molecular mechanisms. Nucleic Acids Res. 27: 318-322.
40. Masternak, K., N. Peyraud, M. Krawczyk, E. Barras, and W. Reith. 2003. Chromatin remodeling and extragenic transcription at the MHC class II locus control region. Nat. Immunol. 4: 132-137.
41. Celada, A., S. McKercher, and R. A. Maki. 1993. Repression of major histocompatibility complex IA expression by glucocorticoids: the glucocorticoid receptor inhibits the DNA binding of the X box DNA binding protein. J. Exp. Med. 177: 691-698.
42. Bennett, B. L., D. T. Sasaki, B. W. Murray, E. C. O'Leary, S. T. Sakata, W. Xu, J. C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, et al. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98: 13681-13686.
43. Cuenda, A., J. Rouse, Y. N. Doza, R. Meier, P. Cohen, T. F. Gallagher, P. R. Young, and J. C. Lee. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364: 229-233.
44. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270: 27489-27494.
45. Sanchez-Tillo, E., M. Comalada, C. Farrera, A. F. Valledor, J. Lloberas, and A. Celada. 2006. Macrophage-colony-stimulating factor-induced proliferation and lipopolysaccharide-dependent activation of macrophages requires raf-I phosphorylation to induce mitogen kinase phosphatase-1 expression. J. Immunol. 176: 6594-6602.
46. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388: 782-787.
47. Askew, D., R. S. Chu, A. M. Krieg, and C. V. Harding. 2000. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms. J. Immunol. 165: 6889-6895.
48. Landmann, S., A. Muhlethaler-Mottet, L. Bernasconi, T. Suter, J. M. Waldburger, K. Masternak, J. F. Arrighi, C. Hauser, A. Fontana, and W. Reith. 2001. Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression. J. Exp. Med. 194: 379-391.
49. Pai, R. K., D. Askew, W. H. Boom, and C. V. Harding. 2002. Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator. J. Immunol. 169: 1326-1333.
50. Kuchtey, J., M. Pennini, R. K. Pai, and C. V. Harding. 2003. CpG DNA induces a class II transactivator-independent increase in class II MHC by stabilizing class II MHC mRNA in B lymphocytes. J. Immunol. 171: 2320-2325.
51. Bevilacqua, A., M. C. Ceriani, S. Capaccioli, and A. Nicolin. 2003. Post-transcriptional regulation of gene expression by degradation of messenger RNAs. J. Cell. Physiol. 195: 356-372.
52. Barreau, C., L. Paillard, and H. B. Osborne. 2005. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 33: 7138-7150.
53. Bauer, S., C. J. Kirschning, H. Hacker, V. Redecke, S. Hausmann, S. Akira, H. Wagner, and G. B. Lipford. 2001. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA 98: 9237-9242.
54. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
55. Dean, A. 2006. On a chromosome far, far away: LCRs and gene expression. Trends Genet. 22: 38-45.
56. Shaulian, E., and M. Karin. 2002. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4: E131-E136.
57. Chang, L., and M. Karin. 2001. Mammalian MAP kinase signalling cascades. Nature 410: 37-40.
58. Cavigelli, M., F. Dolfi, F. X. Claret, and M. Karin. 1995. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 14: 5957-5964.
59. Monje, P., M. J. Marinissen, and J. S. Gutkind. 2003. Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor. Mol. Cell. Biol. 23: 7030-7043.
60. Murphy, L. O., S. Smith, R. H. Chen, D. C. Fingar, and J. Blenis. 2002. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4: 556-564.
61. Tanos, T., M. J. Marinissen, F. C. Leskow, D. Hochbaum, H. Martinetto, J. S. Gutkind, and O. A. Coso. 2005. Phosphorylation of c-Fos by members of the p38 MAPK family: role in the AP-1 response to UV light. J. Biol. Chem. 280: 18842-18852.
62. Hunt, A. E., L. M. Williams, F. V. Lali, and B. M. Foxwell. 2002. IL-4 regulation of p38 MAPK signalling is dependent on cell type. Cytokine 18: 295-303.
63. Triantafilou, M., and K. Triantafilou. 2005. The dynamics of LPS recognition: complex orchestration of multiple receptors. J. Endotoxin Res. 11: 5-11.
64. Villadangos, J. A., P. Schnorrer, and N. S. Wilson. 2005. Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces. Immunol. Rev. 207: 191-205.